- Home
- MODV vs KPTI Comparison
MODV vs KPTI Comparison
Compare MODV & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- KPTI
- Stock Information
- Founded
- MODV 1996
- KPTI 2008
- Country
- MODV United States
- KPTI United States
- Employees
- MODV N/A
- KPTI N/A
- Industry
- MODV Transportation Services
- KPTI Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- KPTI Health Care
- Exchange
- MODV Nasdaq
- KPTI Nasdaq
- Market Cap
- MODV 48.9M
- KPTI 44.5M
- IPO Year
- MODV N/A
- KPTI 2013
- Fundamental
- Price
- MODV $3.32
- KPTI $4.21
- Analyst Decision
- MODV Buy
- KPTI Strong Buy
- Analyst Count
- MODV 4
- KPTI 7
- Target Price
- MODV $9.17
- KPTI $45.43
- AVG Volume (30 Days)
- MODV 1.1M
- KPTI 138.8K
- Earning Date
- MODV 08-06-2025
- KPTI 08-05-2025
- Dividend Yield
- MODV N/A
- KPTI N/A
- EPS Growth
- MODV N/A
- KPTI N/A
- EPS
- MODV N/A
- KPTI N/A
- Revenue
- MODV $2,753,789,000.00
- KPTI $142,126,000.00
- Revenue This Year
- MODV N/A
- KPTI $2.09
- Revenue Next Year
- MODV $4.90
- KPTI $12.90
- P/E Ratio
- MODV N/A
- KPTI N/A
- Revenue Growth
- MODV N/A
- KPTI 1.19
- 52 Week Low
- MODV $0.87
- KPTI $3.51
- 52 Week High
- MODV $32.82
- KPTI $16.95
- Technical
- Relative Strength Index (RSI)
- MODV 59.45
- KPTI 41.48
- Support Level
- MODV $3.01
- KPTI $4.23
- Resistance Level
- MODV $3.74
- KPTI $5.14
- Average True Range (ATR)
- MODV 0.43
- KPTI 0.38
- MACD
- MODV -0.01
- KPTI 0.04
- Stochastic Oscillator
- MODV 60.58
- KPTI 24.45
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.